We found that the high-risk group was strongly linked with older age, GBM (glioblastoma, WHO grade 4), IDH-wildtype, 1p/19q non-codeletion, MGMT promoter unmethylation and classical or mesenchymal subtypes (p < 0.001). This evidence concerns the gene MGMT and glioblastoma.